General Information of Drug (ID: DM460D1)

Drug Name
PMID27336223-Compound-8 Drug Info
Cross-matching ID
PubChem CID
1714884
ChEBI ID
CHEMBL425027
CAS Number
CAS 59662-49-6
TTD Drug ID
D0M5EC

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
DNA replication 2.39 0.00e+0 34/36 (94.44%) MCM3;MCM2;POLE2;...
Spliceosome 2.23 0.00e+0 101/150 (67.33%) HNRNPM;FUS;SNRNP40;...
Mismatch repair 2.06 3.34e-3 22/23 (95.65%) RPA3;LIG1;PCNA;...
Fanconi anemia pathway 2.05 2.51e-3 36/54 (66.67%) BLM;HES1;FANCG;...
Ribosome biogenesis in eukaryotes 2.05 2.01e-3 52/108 (48.15%) NOP56;MDN1;EIF6;...
Cell cycle 2.01 1.67e-3 110/124 (88.71%) PLK1;CDC25A;MCM3;...
Pyrimidine metabolism 1.99 2.87e-3 40/56 (71.43%) RRM2;TYMS;ENTPD3;...
Base excision repair 1.89 6.27e-3 29/33 (87.88%) PARP2;POLE2;PARP1;...
RNA transport 1.76 3.79e-2 128/186 (68.82%) NUP62;TACC3;PNN;...
Acute myeloid leukemia 1.72 4.52e-2 66/67 (98.51%) DUSP6;CCND1;CCNA2;...
mRNA surveillance pathway 1.71 4.56e-2 71/98 (72.45%) PPP2R1B;PNN;FUS;...
Homologous recombination 1.71 4.18e-2 35/41 (85.37%) BLM;RPA3;BRCA1;...
African trypanosomiasis 1.69 4.94e-2 32/37 (86.49%) PRKCA;HBB;F2RL1;...
IL-17 signaling pathway 1.69 4.66e-2 84/94 (89.36%) CCL2;FOSL1;MUC5B;...
Progesterone-mediated oocyte maturation 1.67 4.95e-2 75/100 (75%) PLK1;CDC25A;AURKA;...
Collecting duct acid secretion -1.62 4.78e-2 22/27 (81.48%) ATP6V0C;ATP6V1B2;ATP6V0E1;...
Ferroptosis -1.64 4.09e-2 36/41 (87.8%) NCOA4;FTL;GPX4;...
Folate biosynthesis -1.66 3.71e-2 23/26 (88.46%) TH;GGH;PTS;...
mTOR signaling pathway -1.67 3.69e-2 114/154 (74.03%) FZD3;MAP2K1;LPIN2;...
Phagosome -1.72 2.12e-2 118/152 (77.63%) HLA-C;HLA-B;THBS3;...
Intestinal immune network for IgA production -1.73 1.99e-2 38/48 (79.17%) ITGB7;IL4;CD40;...
Asthma -1.75 1.85e-2 25/31 (80.65%) IL4;CD40;HLA-DOA;...
Viral myocarditis -1.78 1.38e-2 53/60 (88.33%) CXADR;RAC3;HLA-C;...
Type I diabetes mellitus -1.79 1.41e-2 38/43 (88.37%) HLA-C;HLA-B;IL1A;...
Autophagy -1.81 1.09e-2 113/169 (66.86%) PPP2CA;CTSL;MRAS;...
Other glycan degradation -1.82 1.20e-2 13/18 (72.22%) HEXB;FUCA1;AGA;...
Glycosaminoglycan degradation -1.84 7.75e-3 19/19 (100%) SGSH;GUSB;IDUA;...
Graft-versus-host disease -1.85 7.47e-3 32/42 (76.19%) HLA-C;HLA-B;IL1A;...
Autoimmune thyroid disease -1.86 5.69e-3 46/53 (86.79%) TPO;HLA-C;HLA-B;...
Hematopoietic cell lineage -1.87 6.64e-3 90/99 (90.91%) IL1A;EPOR;IL4;...
Lysosome -1.94 3.99e-3 115/128 (89.84%) CTSW;PPT1;CLN5;...
Primary immunodeficiency -1.97 2.49e-3 33/38 (86.84%) ZAP70;CD40;AICDA;...
Allograft rejection -2.02 0.00e+0 32/38 (84.21%) HLA-C;HLA-B;IL4;...
Mitophagy -2.21 0.00e+0 56/68 (82.35%) CSNK2A2;MFN1;MRAS;...
Steroid biosynthesis -2.29 0.00e+0 19/20 (95%) TM7SF2;FDFT1;NSDHL;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Ewing sarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-673 CVCL_0080 Homo sapiens 10uM 6H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.04uM - 10uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
CL-34 CVCL_1123 Homo sapiens 10uM 6H
HT-29 CVCL_0320 Homo sapiens 0.04uM - 10uM 6H, 24H
LoVo CVCL_0399 Homo sapiens 10uM 6H
MDST8 CVCL_1400 Homo sapiens 10uM 6H
NCI-H508 CVCL_1561 Homo sapiens 10uM 6H
SNU-1040 CVCL_5001 Homo sapiens 10uM 6H
SNU-C4 CVCL_5008 Homo sapiens 10uM 6H
SNU-C5 CVCL_5009 Homo sapiens 10uM 6H
SW480 CVCL_0546 Homo sapiens 10uM 6H
SW620 CVCL_0547 Homo sapiens 10uM 6H
SW948 CVCL_0550 Homo sapiens 10uM 6H
Colorectal carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCT 116 CVCL_0291 Homo sapiens 10uM 6H
HT115 CVCL_1294 Homo sapiens 10uM 6H
RKO CVCL_0504 Homo sapiens 10uM 6H
Endometrium
Endometrial adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEC-108 CVCL_2926 Homo sapiens 10uM 6H
SNG-M CVCL_1707 Homo sapiens 10uM 6H
Endometrial carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
JHUEM-2 CVCL_1327 Homo sapiens 10uM 6H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.04uM - 10uM 6H, 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 0.04uM - 10uM 6H, 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.04uM - 10uM 6H, 24H
DV-90 CVCL_1184 Homo sapiens 10uM 6H
SK-LU-1 CVCL_0624 Homo sapiens 10uM 6H
Lung adenosquamous carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H596 CVCL_1571 Homo sapiens 10uM 6H
Lung large cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
COR-L23 CVCL_1133 Homo sapiens 10uM 6H
T3M-10 CVCL_1729 Homo sapiens 10uM 6H
Lung squamous cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC15 CVCL_1253 Homo sapiens 10uM 6H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H1299 CVCL_0060 Homo sapiens 10uM 6H
HCC515 CVCL_5134 Homo sapiens 0.04uM - 10uM 6H, 24H
NCI-H2073 CVCL_1523 Homo sapiens 10uM 6H
Small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H1694 CVCL_1495 Homo sapiens 10uM 6H
NCI-H1836 CVCL_1502 Homo sapiens 10uM 6H
Lymph node
Diffuse large B-cell lymphoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
WSU-DLCL2 CVCL_1787 Homo sapiens 10uM 6H
Ovary
Ovarian carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
EFO-27 CVCL_1194 Homo sapiens 10uM 6H
OV7 CVCL_1623 Homo sapiens 10uM 6H
Ovarian clear cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
RMG-I CVCL_1663 Homo sapiens 10uM 6H
Ovarian mucinous cystadenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
COV644 CVCL_2011 Homo sapiens 10uM 6H
RMUG-S CVCL_1666 Homo sapiens 10uM 6H
Ovarian undifferentiated carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
TYK-nu CVCL_1774 Homo sapiens 10uM 6H
Peripheral blood
Acute monocytic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
THP-1 CVCL_0006 Homo sapiens 10uM 6H
Acute myeloid leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NOMO-1 CVCL_1609 Homo sapiens 10uM 6H
PL-21 CVCL_2161 Homo sapiens 10uM 6H
SKM-1 CVCL_0010 Homo sapiens 10uM 6H
Pleural effusion
Histiocytic lymphoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-937 CVCL_0007 Homo sapiens 10uM 6H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 0.04uM - 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.04uM - 10uM 6H, 24H
SK-MEL-1 CVCL_0523 Homo sapiens 10uM 6H
SK-MEL-28 CVCL_0526 Homo sapiens 10uM 6H
Stomach
Gastric adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
AGS CVCL_0139 Homo sapiens 10uM 6H